The future of prodrugs – design by quantum mechanics methods

Bibliography

• Albert A. Chemical aspects of selective toxicity. Nature 1958;182:421-2
   PubMed Web of Science ®Google Scholar
• Stella VJ, Borchardt RT, Hageman MJ, Prodrugs: challenges and rewards part 1 and 2. Springer Science + Business Media, New York; 2007
   Google Scholar
• Stella VJ, Charman WN, Naringrekar VH. Prodrugs. Do they have advantages in clinical practice? Drugs 1985;29:455-73
   PubMed Web of Science ®Google Scholar
• Banerjee PK, Amidon GL. Design of prodrugs based on enzymes-substrate specificity. In: Bundgaard H, editor. Design of prodrugs. Elsevier, New York; 1985. p. 93-133
   Google Scholar
• Müller CE. Prodrug approaches for enhancing the bioavailability of drugs with low solubility. Chem Biodivers 2009;6:2071-83
   PubMed Web of Science ®Google Scholar
• Roche EB. Design of biopharmaceutical properties through prodrugs and analogs. American Pharmaceutical Association, Washington, DC; 1977
   Google Scholar
• Stella V. Pro-drugs: an overview and definition. In: Higuchi T, Stella V, editors. Prodrugs as novel drug delivery systems. ACS Symposium Series American Chemical Society, Washington, DC; 1975. p. 1-115
   Google Scholar
• Amidon GL, Leesman GD, Elliott RL. Improving intestinal absorption of water-insoluble compounds: a membrane metabolism strategy. J Pharm Sci 1980;69:1363-8
   PubMed Web of Science ®Google Scholar
• Fleisher D, Stewart BH, Amidon GL. Design of prodrugs for improved gastrointestinal absorption by intestinal enzyme targeting. Methods Enzymol 1985;112:360-81
   PubMed Web of Science ®Google Scholar
• Bai JP, Amidon GL. Structural specificity of mucosal-cell transport and metabolism of peptide drugs: implication for oral peptide drug delivery. Pharm Res 1992;9:969-78
   PubMed Web of Science ®Google Scholar
• Stella VJ, Himmelstein KJ. Prodrugs and site-specific drug delivery. J Med Chem 1980;23:1275-82
   PubMed Web of Science ®Google Scholar
• Stella VJ, Himmelstein KJ. Critique of prodrugs and site specific delivery. In: Bundgaard H, editor. Optimization of drug delivery. Alfred Benzon Symposium Munksgaard, Copenhagen; 1982. p. 134-55
   Google Scholar
• Friend DR, Chang GW. A colon-specific drug-delivery system based on drug glycosides and the glycosidases of colonic bacteria. J Med Chem 1984;27:261-6
   PubMed Web of Science ®Google Scholar
• Philpott GW, Shearer WT, Bower RJ, Parker CW. Selective cytotoxicity of hapten-substituted cells with an antibody-enzyme conjugate. J Immunol 1973;111:921-9
   PubMed Web of Science ®Google Scholar
• Deonarain MP, Spooner RA, Epenetos AA. Genetic delivery of enzymes for cancer therapy. Gene Ther 1996;2:235-44
   Web of Science ®Google Scholar
• Singhal S, Kaiser LR. Cancer chemotherapy using suicide genes. Surg Oncol Clin North Am 1998;7:505-36
   PubMedGoogle Scholar
• Aghi M, Hochberg F, Breakefield XO. Prodrug activation enzymes in cancer gene therapy. J Gene Med 2000;2:148-64
   PubMed Web of Science ®Google Scholar
• Greco O, Dachs GU. Gene directed enzyme/prodrug therapy of cancer: historical appraisal and future prospectives. J Cell Physiol 2001;187:22-36
   PubMed Web of Science ®Google Scholar
• Di L, Kerns EH. Solubility issues in early discovery and HTS. In: Augustijins P, Brewster M, editors. Solvent systems and their selection in pharmaceutics and biopharmaceutics. Springer Science + Business Media, New York; 2007. p. 111-36
   Google Scholar
• Fleisher D, Bong R, Stewart BH. Improved oral drug delivery: solubility limitations overcome by the use of prodrugs. Adv Drug Deliv Rev 1996;19:115-30
   Web of Science ®Google Scholar
• Chan OH, Stewart BH. Physicochemical and drug-delivery considerations for oral drug bioavailability. Drug Discov Today 1996;1:461-73
   Web of Science ®Google Scholar
• Beaumont K, Webster R, Gardner I, Dack K. Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: challenges to the discovery scientist. Curr Drug Metab 2003;4:461-85
   PubMed Web of Science ®Google Scholar
• Gonzalez FJ, Tukey RH. Drug metabolism. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman and Gilman's the pharmacological basis of therapeutics. The McGraw-Hill Companies, Inc, New York; 2006. p. 71-91
   Google Scholar
• Testa B, Krämer SD. The biochemistry of drug metabolism–an introduction: part 2. Redox reactions and their enzymes. Chem Biodivers 2007;4:257-405
   PubMed Web of Science ®Google Scholar
• Gangwar S, Pauletti GM, Wang B, Prodrug strategies to enhance the intestinal absorption of peptides. DDT 1997;2:148-55
   Web of Science ®Google Scholar
• Wang W, Jiang J, Ballard CE, Wang B. Prodrug approaches to the improved delivery of peptide drugs. Curr Pharm Des 1999;5:265-87
   PubMed Web of Science ®Google Scholar
• Draganov DI, La Du BN. Pharmacogenetics of paraoxonases: a brief review. Naunyn Schmiedebergs Arch Pharmacol 2004;369:78-88
   PubMed Web of Science ®Google Scholar
• Moser VC, Chanda SM, Mortensen SR, Padilla S. Age- and gender-related differences in sensitivity to chlorpyrifos in the rat reflect developmental profiles of esterase activities. Toxicol Sci 1998;46:211-22
   PubMed Web of Science ®Google Scholar
• Dahan A, Khamis M, Agbaria R, Karaman R. Targeted prodrugs in oral drug delivery. The modern molecular biopharmaceutical approach. Expert Opin Drug Deliv 2012;9:1001-13
   PubMed Web of Science ®Google Scholar
• Bruice TC, Benkovic SJ. Bioorganic mechanisms. Volumes I and II Benjamin, Reading, MA; 1966
   Google Scholar
• Jencks WP. Catalysis in chemistry and enzymology. McGraw, New York; 1969
   Google Scholar
• Nelson DL, Cox MM. Lehninger principles of biochemistry. Worth, New York; 2003
   Google Scholar
• Fersht A. Structure and mechanism in protein science: a guide to enzyme catalysis and protein folding. WH. Freeman and Co, New York; 1999
   Google Scholar
• Kirby AJ, Lancaster PW. Structure and efficiency in intramolecular and enzymatic catalysis. Catalysis of amide hydrolysis by the carboxy-group of substituted maleamic acids. J Chem Soc Perkin Trans 1972;2:1206-14
   Google Scholar
• Kirby AJ, Hollfelder F. From enzyme models to model enzymes. 1st edition. RSC Publishing, United Kingdom; 2009
   Google Scholar
• Kirby AJ, Parkinson A. Most efficient intramolecular general acid catalysis of acetal hydrolysis by the carboxyl group. J Chem Soc Chem Commun 1994;707-8
   Google Scholar
• Brown CJ, Kirby AJ. Efficiency of proton transfer catalysis. Intramolecular general acid catalysis of the hydrolysis of dialkyl acetals of benzaldehyde. J Chem Soc Perkin Trans 1997;2:1081-93
   Google Scholar
• Craze G-A, Kirby AJ. The hydrolysis of substituted 2-methoxymethoxybenzoic acids. J Chem Soc Perkin Trans 1974;2:61-6
   Google Scholar
• Barber SE, Dean KES, Kirby AJ. A mechanism for efficient proton-transfer catalysis. Intramolecular general acid catalysis of the hydrolysis of 1-arylethyl ethers of salicylic acid. Can J Chem 1999;792-801
   Web of Science ®Google Scholar
• Kirby AJ, de Silva MF, Lima D, Efficient intramolecular general acid catalysis of nucleophilic attack on a phosphodiester. J Am Chem Soc 2006;128:16944-52
   PubMed Web of Science ®Google Scholar
• Hartwell E, Hodgson DRW, Kirby AJ. Exploring the limits of efficiency of proton-transfer catalysis in models and enzymes. J Am Chem Soc 2000;122:9326-7
   Web of Science ®Google Scholar
• Kirby AJ. Efficiency of proton transfer catalysis in models and enzymes. Acc Chem Res 1997;30:290-6
   Web of Science ®Google Scholar
• Asaad N, Davies JE, Hodgson DRW, Kirby AJ. The search for efficient intramolecular proton transfer from carbon: the kinetically silent intramolecular general base-catalysed elimination reaction of O-phenyl 8-dimethylamino-1-naphthaldoximes. J Phys Org Chem 2005;18:101-9
   Web of Science ®Google Scholar
• Menger FM, Chow JF, Kaiserman H, Vasquez PC. Directionality of proton transfer in solution: three systems of known angularity. J Am Chem Soc 1983;105:4996-5002
   Web of Science ®Google Scholar
• Menger FM. On the source of intramolecular and enzymatic reactivity. Acc Chem Res 1985;18:128-34
   Web of Science ®Google Scholar
• Menger FM. Directionality of organic reactions in solution. Tetrahedron 1983;39:1013-40
   Web of Science ®Google Scholar
• Menger FM, Ladika M. Fast hydrolysis of an aliphatic at neutral pH and ambient temperature. A peptidase model. J Am Chem Soc 1988;110:6794-6
   Web of Science ®Google Scholar
• Menger FM, Galloway AL, Musaev DG. Relationship between rate and distance. Chem Commun 2003;9:2370-1
   Google Scholar
• Menger FM. An alternative view of enzyme catalysis. Pure Appl Chem 2005;77:1873-86
   Web of Science ®Google Scholar
• Milstien S, Cohen LA. Concurrent general-acid and general-base catalysis of esterification. J Am Chem Soc 1970;92:4377-82
   Web of Science ®Google Scholar
• Greenwald RB, Choe YH, Conover CD, Drug delivery systems based on trimethyl lock lactonization: poly(ethylene glycol) prodrugs of amino-containing compounds. J Med Chem 2000;43:475-87
   PubMed Web of Science ®Google Scholar
• Golik J, Wong HSL, Chen SH, Synthesis and antitumor evaluation of paclitaxel phosphonooxymethyl ethers: a novel class of water soluble paclitaxel pro-drugs. Bioorg Med Chem Lett 1996;6(15):1837-42
   Web of Science ®Google Scholar
• Bruice TC, Pandit UK. The effect of geminal substitution ring size and rotamer distribution on the intramolecular nucleophilic catalysis of the hydrolysis of monophenyl esters of dibasic acids and the solvolysis of the intermediate anhydrides. J Am Chem Soc 1960;82:5858-65
   Web of Science ®Google Scholar
• Bruice TC, Pandit UK. Intramolecular models depicting the kinetic importance of “Fit” in enzymatic catalysis. Proc Natl Acad Sci USA 1960;46:402-4
   PubMed Web of Science ®Google Scholar
• Reddy MR, Erion MD. Free energy calculations in rational drug design. Kluwer Academic/Plenum Publishers, New York, NY, USA; 2001. p. 379
   Google Scholar
• Parr RG, Craig DP, Ross IG. Molecular orbital calculations of the lower excited electronic levels of benzene, configuration interaction included. J Chem Phys 1950;18(12):1561-3
   Web of Science ®Google Scholar
• Parr RG. On the genesis of a theory. Int J Quantum Chem 1990;37(4):327-47
   Web of Science ®Google Scholar
• Chen TC. Expansion of electronic wave functions of molecules in terms of ‘United-Atom' wave functions. J Chem Phys 1955;23(11):2200-1
   Web of Science ®Google Scholar
• Dewar MJS, Thiel W. Ground states of molecules. The MNDO method. Approximations and parameters. J Am Chem Soc 1977;99:4899-907
   Web of Science ®Google Scholar
• Bingham RC, Dewar MJS, Lo DH. Ground states of molecules. XXV. MINDO/3. An improved version of the MNDO semiempirical SCF-MO method. J Am Chem Soc 1975;97:1285-93
   Web of Science ®Google Scholar
• Dewar MJS, Zoebisch EG, Healy EF, Stewart JJP. AM1: a new general purpose quantum mechanical molecular model. J Am Chem Soc 1985;107:3902-7
   Web of Science ®Google Scholar
• Dewar MJS, Jie C, Yu J. The first of new series of general purpose quantum mechanical molecular models. Tetrahedron 1993;49:5003-38
   Web of Science ®Google Scholar
• Parr RG, Yang W. Density functional theory of atoms and molecules. Oxford University Press, Oxford; 1989
   Google Scholar
• Burkert U, Allinger NL. Molecular mechanics (ACS Monograph). American Chemical Society, Washington, DC; 1982. p. 177
   Google Scholar
• Warshel A, Levitt M. Theoretical studies of enzymatic reactions: dielectric, electrostatic and steric stabilization of the carbonium ion in the reaction of lysozyme. J Mol Biol 1976;103(2):227-49
   PubMed Web of Science ®Google Scholar
• Field MJ. Simulating enzyme reactions: challenges and perspectives. J Comput Chem 2002;23(1):48-58
   PubMed Web of Science ®Google Scholar
• Mulholland AJ. Modelling enzyme reaction mechanisms, specificity and catalysis. Drug Discov Today 2005;10(20):1393-402
   PubMed Web of Science ®Google Scholar
• Karaman R. A new mathematical equation relating activation energy to bond angle and distance: a key for understanding the role of acceleration in lactonization of the trimethyl lock system. Bioorg Chem 2009;37:11-25
   PubMed Web of Science ®Google Scholar
• Karaman R. The role of proximity orientation in intramolecular proton transfer reactions. J Comput Theor Chem 2011;966:311-21
   Web of Science ®Google Scholar
• Karaman R. Analyzing the efficiency in intramolecular amide hydrolysis of Kirby's N-alkylmaleamic acids - a computational approach. Comput Theor Chem 2011;974:133-42
   Web of Science ®Google Scholar
• de Miranda P, Blum MR. Pharmacokinetics of acyclovir after intravenous and oral administration. J Antimicrob Chemother 1983;12(Suppl B):29-37
   PubMed Web of Science ®Google Scholar
• Blum MR, Liao SHT, de Miranda P. Overview of aciclovir pharmacokinetic disposition in adults and children. Am J Med 1982;73(Suppl 1A):186-92
   PubMed Web of Science ®Google Scholar
• Luengo J, Aranguiz T, Sepulveda J. Preliminary pharmacokinetic study to different preparations of acyclovir with beta-cyclodextrin. J Pharm Sci 2002;91:2593-8
   PubMed Web of Science ®Google Scholar
• Attia IA, El-Gizawy SA, Fouda MA, Donia AM. Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits. AAPS Pharm Sci Tech 2007;8(4):E106
   PubMed Web of Science ®Google Scholar
• Yadav S, Jain S, Prajapati S, Formulation and in vitro and in vivo characterization of acyclovir loaded mucoadhesive microspheres. J Pharm Sci Tech 2011;3(1):441-7
   Google Scholar
• Soul-Lawton J, Seaber E, On N, Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans. Antimicrob Agents Chemother 1995;39:2759-64
   PubMed Web of Science ®Google Scholar
• Tolle-Sander S, Lentz KA, Maeda DY, Increased acyclovir oral bioavailability via a bile acid conjugate. Mol Pharm 2004;1:40-8
   PubMed Web of Science ®Google Scholar
• Foppa T, Murakami FS, Silva MA. Development, validation and stability study of pediatric atenolol syrup. Pharmazie 2007;62(7):519-21
   PubMed Web of Science ®Google Scholar
• Anroop B, Ghosh B, Parcha V, Khanam J. Transdermal delivery of atenolol: effect of prodrugs and iontophoresis. Curr Drug Deliv 2009;6(3):280-90
   PubMedGoogle Scholar
• Mcainsh J, Simpson WT, Holmes BF, Bioavailability of atenolol formulations. Biopharm Drug Dispos 1980;1(6):223-32
   Google Scholar
• Vergin H, Nitsche V. Oral bioavailability of atenolol. J Int Med Res 1989;17(5):417-25
   PubMed Web of Science ®Google Scholar
• Shin S-C, Choi J-S. Enhanced bioavailability of atenolol by transdermal administration of the ethylene-vinyl acetate matrix in rabbits. Eur J Pharm Biopharm 2003;56(3):439-43
   PubMed Web of Science ®Google Scholar
• Chan K, Swenden J. Pilot study of the short-term physico-chemical stability of atenolol tablets stored in a multi-compartment compliance aid. Eur J Hosp Pharm Sci 2007;13(3):60-6
   Google Scholar
• Finn A, Straugun A, Meyer M, Chubb J. Effect of dose and food on the bioavailability of cefuroxime axetil. Biopharm Drug Dispos 1987;8:519-26
   PubMed Web of Science ®Google Scholar
• Patel AR, Vavia PR. Preparation and evaluation of taste masked famotidine formulation using drug/beta-cyclodextrin/polymer ternary complexation approach. AAPS Pharm Sci Tech 2008;9(2):544-50
   PubMed Web of Science ®Google Scholar
• Bora D, Borude P, Bhise K. Taste masking by spray-drying technique. AAPS PharmSci Tech 2008;9(4):1159-64
   PubMed Web of Science ®Google Scholar
• Yajima T, Nogata A, Demachi M, Particle design for taste-masking using a spray-congealing technique. Chem Pharm Bull 1996;44(1):187-91
   Web of Science ®Google Scholar
• Shidhaye S, Malke S, Kadam V. Taste masked, orally disintegrating tablet containing microspheres for immediate release. J Pharm Res 2008;1:225-9
   Google Scholar
• Perry CM, Brogden RN. Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1996;52(1):125-58
   PubMed Web of Science ®Google Scholar
• Karaman R, Dajani KK, Qtait A, Khamis M. Prodrugs of acyclovir - a computational approach. Chem Biol Drug Des 2012;79:819-34
   PubMed Web of Science ®Google Scholar
• Karaman R, Dajani KK, Hallak H. Computer-assisted design for atenolol prodrugs for the use in aqueous formulations. J Mol Model 2012;18:1523-40
   PubMed Web of Science ®Google Scholar
• Karaman R. Prodrugs for masking bitter taste of antibacteria drugs – a computational approach. J Mol Model 2013; Epub ahead of print
   Web of Science ®Google Scholar
• Karaman R. The efficiency of proton transfer in Kirby's enzyme model, a computational approach. Tetrahedron Lett 2010;51:2130-5
   Web of Science ®Google Scholar
• Karaman R, Pascal RA. Computational analysis of intramolecularity in proton transfer reactions. Org Bimol Chem 2010;8:5174-8
   PubMed Web of Science ®Google Scholar
• Karaman R. Analysis of Menger's spatiotemporal hypothesis. Tetrahedron Lett 2008;49:5998-6002
   Web of Science ®Google Scholar
• Karaman R. The effective molarity (EM) – a computational approach. Bioorg Chem 2010;38:165-72
   PubMed Web of Science ®Google Scholar
• Blum W, Klisovic RB, Hackanson B, Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia. J Clin Oncol 2007;25:3884-91
   PubMed Web of Science ®Google Scholar
• Silverman LR, McKenzie DR, Peterson BL, Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B. J Clin Oncol 2006;24:3895-903
   PubMed Web of Science ®Google Scholar
• Available from: http://www.assistpainrelief.com/dyn/304/Paracetamol.html
   Google Scholar
• Available from: http://www.chemicalbook.com/ChemicalProductProperty_EN_CB6141828.htm
   Google Scholar
• Available from: http://www.chemicalall.com/chemicals-name-a/acetanilide.html
   Google Scholar
• Comley JC, Yeates CL, Frend TJ. Antipneumocystis activity of 17C91, a prodrug of atovaquone. Antimicrob Agents Chemother 1995;39(10):2217-19
   PubMed Web of Science ®Google Scholar
• Malarone prescribing. Available from: http://us.gsk.com/products/assets/us_malarone.pdf
   Google Scholar
• Karaman R. Prodrugs of Aza nucleosides based on proton transfer reactions. J Comput Aided Mol Des 2010;24:961-70
   PubMed Web of Science ®Google Scholar
• Hejaz H, Karaman R, Khamis M. Computer-assisted design for paracetamol masking bitter taste prodrugs. J Mol Model 2012;18:103-14
   PubMed Web of Science ®Google Scholar
• Karaman R, Hallak H. Anti-malarial pro-drugs – a computational aided design. Chem Biol Drug Des 2010;76:350-60
   PubMed Web of Science ®Google Scholar
• Karaman R. Cleavage of Menger's aliphatic amide: a model for peptidase enzyme solely explained by proximity orientation in intramolecular proton transfer. J Mol Struct (THEOCHEM) 2009;910:27-33
   Web of Science ®Google Scholar
• De Stefano A, Sozio P, Cerasa LS. Antiparkinson prodrugs. Molecules 2008;13:46-68
   PubMed Web of Science ®Google Scholar
• Benes FM. Carlsson and the discovery of dopamine. Trends Pharmacol Sci 2001;22:46-7
   PubMed Web of Science ®Google Scholar
• Cyklokapron® tranexamic acid injection prescribing information. Available from: http://www.pfizer.com/files/products/uspi_cyklokapron.pdf
   Google Scholar
• CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010;6736(10):60835-
   Google Scholar
• Levy JH. Antifibrinolytic therapy: new data and new concepts. Comment: Lancet 2010, Published Online; DOI:10.1016/S0140-6736(10)60939-7
   Google Scholar
• Lukes AS, Moore KA, Muse KN, Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial. Obstet Gynecol 2010;116(4):865-75
   PubMed Web of Science ®Google Scholar
• Lysteda® oral tranexamic acid prescribing information. Available from: http://info.lysteda.com/fing/lp_micro_branded/lysteda_pi.pdf
   Google Scholar
• Karaman R. Computational aided design for dopamine prodrugs based on novel chemical approach. Chem Biol Drug Des 2011;78:853-63
   PubMed Web of Science ®Google Scholar
• Karaman R, Dokmak G, Bader M, Prodrugs of fumarate esters for the treatment of psoriasis and multiple sclerosis (MS) – a computational approach. J Mol Model 2013;19:439-52
   PubMed Web of Science ®Google Scholar
• Karaman R. Prodrugs for masking bitter taste of antibacterial drugs – a computational approach. J Mol Model 2013; DOI: 10.1007/s00894-013-1780-5
   Google Scholar
• Fotakis C, Megariotis G, Christodouleas D, Comparative study of the AT1 receptor prodrug antagonist candesartan cilexetil with other sartans on the interactions with membrane bilayers. Biochim Biophys Acta 2012;1818:3107-20
   PubMed Web of Science ®Google Scholar
• Rautio J. Prodrug strategies in drug design. In: Rautio J, editor. Prodrugs and targeted delivery: towards better ADME properties. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim; 2010. p. 1-30
   Google Scholar
• Stella VJ. Prodrugs: some thoughts and current issues. J Pharm Sci 2010;99:4755-65
   PubMed Web of Science ®Google Scholar